![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
|
|
|
AASLD 2019
Prof. Young-Suk LIM
Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine
![0711231](../images/071123/071123-1/0711231.gif)
![0711232](../images/071123/071123-1/0711232.gif)
![0711233](../images/071123/071123-1/0711233.gif)
![0711234](../images/071123/071123-1/0711234.gif)
![0711235](../images/071123/071123-1/0711235.gif)
![0711236](../images/071123/071123-1/0711236.gif)
![0711237](../images/071123/071123-1/0711237.gif)
![0711238](../images/071123/071123-1/0711238.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|